DNA damage induced p53 downregulates Cdc20 by direct binding to its promoter causing chromatin remodeling

Nucleic Acids Research

Volumn 37, Issue 8, 2009, Pages 2688-2698

  Banerjee, Taraswi ^a   Nath, Somsubhra ^a   Roychoudhury, Susanta ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CELL CYCLE PROTEIN 20; ETOPOSIDE; FLUOROURACIL; PROTEIN P21; PROTEIN P53;

ANAPHASE; ARTICLE; BINDING SITE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; GENE REPRESSION; GENOTOXICITY; HUMAN; HUMAN CELL; MITOSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION;

BINDING SITES; CELL CYCLE PROTEINS; CELL LINE; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA DAMAGE; DOWN-REGULATION; HUMANS; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 65849180296     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkp110     Document Type: Article

References (34)

1. Baker,D.J., Dawlaty,M.M., Galardy,P. and van Deursen,J.M. (2007) Mitotic regulation of the anaphase-promoting complex. Cell Mol. Life Sci., 64, 589-600.
2. Musacchio,A. and Salmon,E.D. (2007) The spindle-assembly checkpoint in space and time. Nature Rev., 8, 379-393.
3. Sihn,C.R., Suh,E.J., Lee,K.H., Kim,T.Y. and Kim,S.H. (2003) p55CDC/ hCDC20 mutant induces mitotic catastrophe by inhibiting the MAD2-dependent spindle checkpoint activity in tumor cells. Cancer Lett., 201, 203-210.
4. DeAntoni,A., Sala,V. and Musacchio,A. (2005) Explaining the oligomerization properties of the spindle assembly checkpoint protein Mad2. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 360, 637-647; discussion 447-638.
5. Yoon,Y.M., Baek,K.H., Jeong,S.J., Shin,H.J., Ha,G.H., Jeon,A.H., Hwang,S.G., Chun,J.S. and Lee,C.W. (2004) WD repeat-containing mitotic checkpoint proteins act as transcriptional repressors during interphase. FEBS Lett., 575, 23-29.
6. Chun,A.C. and Jin,D.Y. (2003) Transcriptional regulation of mitotic checkpoint gene MAD1 by p53. J. Biol. Chem., 278, 37439-37450.
7. Kidokoro,T., Tanikawa,C., Furukawa,Y., Katagiri,T., Nakamura,Y. and Matsuda,K. (2008) CDC20, a potential cancer therapeutic target, is negatively regulated by p53. Oncogene, 27, 1562-1571.
8. Ceribelli,M., Alcalay,M., Vigano,M.A. and Mantovani,R. (2006) Repression of new p53 targets revealed by ChIP on chip experiments. Cell Cycle 5, 1102-1110.
9. Johnson,R.A., Ince,T.A. and Scotto,K.W. (2001) Transcriptional repression by p53 through direct binding to a novel DNA element. J. Biol. Chem., 276, 27716-27720.
10. Mirza,A., Wu,Q., Wang,L., McClanahan,T., Bishop,W.R., Gheyas,F., Ding,W., Hutchins,B., Hockenberry,T., Kirschmeier,P. et al. (2003) Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression. Oncogene, 22, 3645-3654.
11. Taylor,W.R. and Stark,G.R. (2001) Regulation of the G2/M transition by p53. Oncogene, 20, 1803-1815.
12. Di Leonardo,A., Khan,S.H., Linke,S.P., Greco,V., Seidita,G. and Wahl,G.M. (1997) DNA rereplication in the presence of mitotic spindle inhibitors in human and mouse fibroblasts lacking either p53 or pRb function. Cancer Res., 57, 1013-1019.
13. Lanni,J.S. and Jacks,T. (1998) Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol. Cell Biol. 18, 1055-1064.
14. Hoyt,M.A., Totis,L. and Roberts,B.T. (1991) S. cerevisiae genes required for cell cycle arrest in response to loss of microtubule function. Cell, 66, 507-517.
15. Sun,Y., Cheung,J.M., Martel-Pelletier,J., Pelletier,J.P., Wenger,L., Altman,R.D., Howell,D.S. and Cheung,H.S. (2000) Wild type and mutant p53 differentially regulate the gene expression of human collagenase-3 (hMMP-13). J. Biol. Chem., 275, 11327-11332.
16. Roperch,J.P., Alvaro,V., Prieur,S., Tuynder,M., Nemani,M., Lethrosne,F., Piouffre,L., Gendron,M.C., Israeli,D., Dausset,J. et al. (1998) Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1 and results in apoptosis and tumor suppression. Nature Med., 4 835-838.
17. Yun,J., Chae,H.D., Choy,H.E., Chung,J., Yoo,H.S., Han,M.H. and Shin,D.Y. (1999) p53 negatively regulates cdc2 transcription via the CCAAT-binding NF-Y transcription factor. J. Biol. Chem., 274, 29677-29682.
18. Wang,Y., Schwedes,J.F., Parks,D., Mann,K. and Tegtmeyer,P. (1995) Interaction of p53 with its consensus DNA-binding site. Mol. Cell Biol., 15, 2157-2165.
19. el-Deiry,W.S., Kern,S.E., Pietenpol,J.A., Kinzler,K.W. and Vogelstein,B. (1992) Definition of a consensus binding site for p53. Nat. Genet. 1, 45-49.
20. Lee,K.C., Crowe,A.J. and Barton,M.C. (1999) p53-mediated repression of alpha-fetoprotein gene expression by specific DNA binding. Mol. Cell Biol., 19, 1279-1288.
21. St Clair,S., Giono,L., Varmeh-Ziaie,S., Resnick-Silverman,L., Liu,W.J., Padi,A., Dastidar,J., DaCosta,A., Mattia,M. and Manfredi,J.J. (2004) DNA damage-induced downregulation of Cdc25C is mediated by p53 via two independent mechanisms: One involves direct binding to the cdc25C promoter. Mol. Cell, 16, 725-736.
22. Mondal,G., Sengupta,S., Panda,C.K., Gollin,S.M., Saunders,W.S. and Roychoudhury,S. (2007) Overexpression of Cdc20 leads to impairment of the spindle assembly checkpoint and aneuploidization in oral cancer. Carcinogenesis, 28, 81-92.
23. Kidokoro,T., Tanikawa,C., Furukawa,Y., Katagiri,T., Nakamura,Y. and Matsuda,K. (2007) CDC20, a potential cancer therapeutic target, is negatively regulated by p53. Oncogene., 27, 1562-1571.
24. Espinosa,J.M. and Emerson,B.M. (2001) Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. Mol. Cell, 8, 57-69.
25. Tabach,Y., Milyavsky,M., Shats,I., Brosh,R., Zuk,O., Yitzhaky,A., Mantovani,R., Domany,E., Rotter,V. and Pilpel,Y. (2005) The promoters of human cell cycle genes integrate signals from two tumor suppressive pathways during cellular transformation. Mol. Systems Biol., 1 20050022.
26. Kanaya,T., Kyo,S., Hamada,K., Takakura,M., Kitagawa,Y., Harada,H. and Inoue,M. (2000) Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription. Clin. Cancer Res., 6, 1239-1247.
27. Scian,M.J., Stagliano,K.E., Deb,D., Ellis,M.A., Carchman,E.H., Das,A., Valerie,K., Deb,S.P. and Deb,S. (2004) Tumor-derived p53 mutants induce oncogenesis by transactivating growth-promoting genes. Oncogene, 23, 4430-4443.
28. Zhang,Y., Wang,J.S., Chen,L.L., Zhang,Y., Cheng,X.K., Heng,F.Y., Wu,N.H. and Shen,Y.F. (2004) Repression of hsp90beta gene by p53 in UV irradiation-induced apoptosis of Jurkat cells. J. Biol. Chem., 279, 42545-42551.
29. Hoffman,W.H., Biade,S., Zilfou,J.T., Chen,J. and Murphy,M. (2002) Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J. Biol. Chem., 277, 3247-3257.
30. Riley,T., Sontag,E., Chen,P. and Levine,A. (2008) Transcriptional control of human p53-regulated genes. Nature Rev., 9, 402-412.
31. Murphy,M., Ahn,J., Walker,K.K., Hoffman,W.H., Evans,R.M., Levine,A.J. and George,D.L. (1999) Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. Genes Dev., 13, 2490-2501.
32. Fukasawa,K., Choi,T., Kuriyama,R., Rulong,S. and Vande Woude,G.F. (1996) Abnormal centrosome amplification in the absence of p53. Science, 271, 1744-1747.
33. Hollstein,M., Rice,K., Greenblatt,M.S., Soussi,T., Fuchs,R., Sorlie,T., Hovig,E., Smith-Sorensen,B., Montesano,R. and Harris,C.C. (1994) Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res., 22, 3551-3555.
34. Makino,K., Yu,D. and Hung,M.C. (2001) Transcriptional upregulation and activation of p55Cdc via p34(cdc2) in Taxol-induced apoptosis. Oncogene, 20, 2537-2543.